Alkermes plc buy melinda
Start price
18.10.17
/
50%
€46.34
Target price
27.10.17
€49.61
Performance (%)
7.49%
End price
27.10.17
€49.82
Summary
This prediction ended on 27.10.17 with a price of €49.82. The BUY prediction by melinda finished with a performance of 7.49%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alkermes plc | -0.800% | -0.800% | -13.287% | 5.689% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread Alkermes plc diskutieren
Biotechnologie und medizinische SecteurRecherche
Neue Studie zur Bewertung der Wirksamkeit von extended-release Naltrexon mit Buprenorphin-Naloxon für Opiatabhängigkeit Veröffentlicht in JAMA Psychiatrie Vergleich